Aging is associated with an increased incidence of
venous thromboembolism (VTE), resulting in significant morbidity and mortality in the elderly. Platelet hyperactivation is linked to aging-related VTE. However, the mechanisms through which aging enhances platelet activation and susceptibility to VTE are poorly understood. In this study, we demonstrated that
mechanistic target of rapamycin complex 1 (
mTORC1) signaling is essential for aging-related platelet hyperactivation and VTE.
mTORC1 was hyperactivated in platelets and megakaryocytes (MKs) from aged mice, accompanied by elevated mean platelet volume (MPV) and platelet activation. Inhibition of
mTORC1 with
rapamycin led to a significant reduction in susceptibility to experimental
deep vein thrombosis (DVT) in aged mice (P < .01). To ascertain the specific role of platelet
mTORC1 activation in DVT, we generated mice with conditional ablation of the mTORC1-specific component gene Raptor in MKs and platelets (Raptor knockout). These mice developed markedly smaller and lighter thrombi, compared with wild-type littermates (P < .01) in experimental DVT. Mechanistically, increased
reactive oxygen species (ROS) production with aging induced activation of
mTORC1 in MKs and platelets, which, in turn, enhanced bone marrow MK size, MPV, and platelet activation to promote aging-related VTE. ROS scavenger administration induced a significant decrease (P < .05) in MK size, MPV, and platelet activation in aged mice. Our findings collectively demonstrate that
mTORC1 contributes to enhanced venous thrombotic susceptibility in aged mice via elevation of platelet size and activation.